The primary objective is to assess the (preliminary) effectiveness of a 4-week home-based exercise training program on an advanced cycle ergometer and the administration of nutritional supplements on preoperative aerobic capacity as measured by the…
ID
Source
Brief title
Condition
- Other condition
- Hepatobiliary neoplasms malignant and unspecified
- Therapeutic procedures and supportive care NEC
Synonym
Health condition
pancreas tumoren
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary endpoint of this study is to assess the (preliminary) effectiveness
of a 4-week home-based exercise training on an advanced cycle ergometer and the
administration of nutritional supplements on preoperative cardiorespiratory
fitness as measured by the anaerobic threshold in high-risk patients (anaerobic
threshold <11 ml/kg/min) scheduled for elective liver or pancreatic resection.
Secondary outcome
Secondary, we will investigate the feasibility of the prehabilitation program
in this patient group by the registration of the number and severity of adverse
events, adherence to the program, patient motivation before and after each
training session, and patient appreciation questionnaire after four weeks.
Other secondary outcome measures include changes in quality of life before and
after the prehabilitation program, changes in steep ramp test outcomes, the
effect of the exercise program on the immune system, changes in other CPET
values, individual changes in physical fitness during the prehabilitation
program, and skeletal muscle metabolic function (energy metabolism). Data on
operative intervention, perioperative outcomes and postoperative progress will
also be collected.
Background summary
The morbidity rates after resection of hepatic and pancreatic tumours are high.
Older patients, especially the frail patients, are more prone to complications
and require specific preoperative risk stratification. The anaerobic threshold
(AT), assessed by cardiopulmonary exercise testing (CPET), can be used to
identify high risk patients. Preoperative exercise prehabilitation can improve
the physical condition of older patients before intra-abdominal surgery. There
is limited evidence regarding the improvement of physical fitness after
exercise prehabilitation in patients undergoing liver or pancreatic resection,
and the feasibility of a prehabilitation program in these patients. Moreover,
to enhance the anabolic effect of physical training, improve lean body mass and
obtain or maintain an optimal nutritional status during the prehabilitation
period, sufficient intake of nutrients is required. We hypothesize that
multimodal prehabilitation (exercise program and nutritional supplements) will
improve the preoperative anaerobic threshold, we assume to reach an average
increase of 1.5 ml/kg/min, in patients with a low cardiorespiratory reserve
(anaerobic threshold <11 ml/kg/min) undergoing elective liver or pancreatic
resection.
Study objective
The primary objective is to assess the (preliminary) effectiveness of a 4-week
home-based exercise training program on an advanced cycle ergometer and the
administration of nutritional supplements on preoperative aerobic capacity as
measured by the anaerobic threshold in high-risk patients (anaerobic threshold
<11 ml/kg/min) scheduled for elective liver or pancreatic resection. Secondary
outcome measures include to assess the feasibility (adherence, adverse events,
motivation, patient appreciation) of the 4-week home-based multimodal program,
changes in other preoperative CPET measures, changes in preoperative quality of
life score, effect of prehabilitation on the immune system by assessing
biomarkers, individual changes in physical fitness and daily physical activity
during the prehabilitation program, and skeletal muscle metabolic function
(energy metabolism). Data on operative intervention, perioperative outcomes and
postoperative progress will also be collected.
Study design
This study is a multicenter study with a pre- en posttest design. It will run
from December 2017 until all patients are included, this will probably be in
June 2020. The study will take place in Medisch Spectrum Twente in Enschede,
Universitair Medisch Centrum Groningen and Maxima Medisch Centrum. If informed
consent is obtained from eligible candidates they will all receive the
prehabilitation program before surgery. A small subgroup will be asked to
perform a second, in-magnet, exercise test at various exercise intensities
using a MR-compatible ergometer 1-2 days after the first and second CPET.
Intervention
Twenty-four patients will receive four weeks (12 sessions in total) of partly
supervised home-based exercise training before surgery. An advanced cycle
ergometer (Lode Corival, Lode BV, Groningen, the Netherlands) will be delivered
at the patients* home. The training program, two sessions a week of interval
training and one session a week of endurance training, twice combined with
periphery muscle training, will be personalized to candidates. The
physiotherapist will visit the patient three times a week in the first week,
and once a week in week 2-4. Patients group will receive protein
supplementation immediately following exercise and (± 30 minutes) before sleep,
providing a standard dosage of 30 g of a high-quality (whey and casein) protein
that contains at least 10 g of EAA, of which 2-3 g leucine. Moreover, patients
will daily receive vitamin D and a multivitamin/mineral supplement. After the
first CPET and prior to the second CPET blood samples will be collected, and
interleukin (IL)-6, IL-8, IL-10, C-reactive protein (CRP), and tumor necrosis
factor (TNF)-* will be measured. In a small subgroup (n=5), an additional,
in-magnet, exercise test using an MR-compatible ergometer will be performed one
or two days after each regular CPET to evaluate the effects of the
prehabilitation program on skeletal muscle metabolic function (energy
metabolism).
Study burden and risks
The risks associated with participation in this study are considered slightly
increased, because the training program is partly unsupervised. But before the
start of the training program a CPET will be performed under controlled
condition under the guidance of trained employees to assess baseline
cardiorespiratory fitness, as well as to examine whether or not there are
contraindications for physical exercise training (safety). The prehabilitation
program will be personalized to each patient based on individual steep ramp
test results. The training program itself will be executed at a submaximal
exercise intensity. We think the slightly increased risk is justified because
of the expectation that the intervention will lead to better fitness and
subsequently to better outcomes.
Koningsplein 1
Enschede 7512 KZ
NL
Koningsplein 1
Enschede 7512 KZ
NL
Listed location countries
Age
Inclusion criteria
- Liver tumour (benign tumour, primary cancer, suspicion of a malignancy, or
colorectal liver metastasis), or pancreatic tumour (pancreatic malignancy,
premalignant pancreatic tumour or the suspicion of a pancreatic malignancy)
requiring resection
- Undergoing elective liver (segmental resection or hemihepatectomy) or
pancreatic surgery (pancreaticoduodenectomy, subtotal or total pancreatectomy)
- Having a life expectancy of more than 6 months
- Has given consent to participate in the study
- Metabolic equivalent score of *7 on the Veterans Specific Activity
Questionnaire
- Anaerobic threshold <11 ml/kg/min after the first CPET
- Will be operated at Medisch Spectrum Twente at Enschede, Universitair Medisch
Centrum Groningen (UMCG) or Maxima Medisch Centrum (MMC)
- Living in Enschede, Oldenzaal, Losser, Lonneker or Glanerbrug
Exclusion criteria
- Not capable to cycle
- Not capable to perform a CPET
- Meeting the absolute and/or relative exclusion criteria from the CPET
protocol used in Medisch Spectrum Twente, UMCG or MMC
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL59702.044.16 |
OMON | NL-OMON27549 |